Forecast of the incidence, prevalence and burden of end-stage renal disease in Nanjing, China to the Year 2025

BMC Nephrology

Volumn 17, Issue 1, 2016, Pages

  Sun, Ling ^a   Zou, Lu Xi ^a   Han, Yu Chen ^a   Huang, Han Ming ^b   Tan, Zhao Ming ^b   Gao, Min ^a   Ma, Kun Ling ^a   Liu, Hong ^a   Liu, Bi Cheng ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b Nanjing Municipal Human Resources and Social Security Bureau   (China)

Author keywords

End stage renal disease; Forecast; Health care costs; Incidence; Medical insurance; Prevalence

Indexed keywords

ARTICLE; CHINESE; END STAGE RENAL DISEASE; FORECASTING; HEALTH CARE COST; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PERITONEAL DIALYSIS; PREVALENCE; TIME SERIES ANALYSIS; CHINA; COST OF ILLNESS; ECONOMICS; HEALTH INSURANCE; KIDNEY FAILURE, CHRONIC; TRENDS;

CHINA; COST OF ILLNESS; FORECASTING; HEALTH BENEFIT PLANS, EMPLOYEE; HEALTH CARE COSTS; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; PREVALENCE;

EID: 84974555743     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/s12882-016-0269-8     Document Type: Article

References (31)

1. Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, Kanbay M, et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet. 2014;383(9931):1831-43.
2. Xie FB, Zhang D, Wu JZ, Zhang YF, Yang Q, Sun XF, et al. Design and implementation of the first nationwide, web-based Chinese Renal Data System (CNRDS). BMC Med Inform Decis. 2012;12:11. doi: 10.1186/1472-6947-12-11.
3. Zuo L, Wang M. Beijing blood purification Q. Current status of maintenance hemodialysis in beijing, china. Kidney Int Suppl. 2013;3(2):167-9. doi: 10.1038/kisup.2013.6.
4. Wei ZM, Lin QJ. Current status of dialysis therapy in Shanghai (results from Shanghai Renal Registry, 2011). Chin J Blood Purif. 2012;11(05):233-6.
5. Yang W-C, Hwang S-J, Taiwan Soc N. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transpl. 2008;23(12):3977-82. doi: 10.1093/ndt/gfn406.
6. ESRD in the United States: An Overview of USRDS Annual Data Report Volume 2. http://www.usrds.org/adr.aspx. (2015). Accessed 13 Feb 2015
7. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with End-stage renal disease in the United States to the year 2010. J Am Soc Nephrol. 2001;12:2753-8.
8. The Renal Association. Report 2014 UK Renal Registry: 17th UKRR Annual Report. http://www.renalreg.org. (2014). Accessed Dec 2014
9. ANZDATA Registry: 2014 Annual Report - 37th Edition. http://www.anzdata.org.au. (2015). Accessed 21 Apr 2015
10. Prestes IV, Moura LD, Duncan BB, Schmidt MI. A national cohort of patients receiving publicly financed renal replacement therapy within the Brazilian Unified Health System. Lancet. 2013;381 Suppl 2:S119.
11. de Moura L, Prestes IV, Duncan BB, Thome FS, Schmidt MI. Dialysis for end stage renal disease financed through the Brazilian National Health System, 2000 to 2012. BMC Nephrol. 2014;15(1):1-6. doi: 10.1186/1471-2369-15-111.
12. Tan J. Renal replacement therapy in Brunei Darussalam: comparing standards with international renal registries. Nephrology. 2014;19(5):288-95. doi: 10.1111/nep.12228.
13. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20:223-8.
14. Cortés-Sanabria L, Cabrera-Pivaral CE, Cueto-Manzano AM, Rojas-Campos E, Barragán G, Hernández-Anaya M, et al. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial. Am J Kidney Dis. 2008;51:777-88.
15. Cueto-Manzano AM, Martinez-Ramlrez HR, Cortes-Sanabria L. Comparison of primary health-care models in the management of chronic kidney disease. Kidney Int Suppl. 2013;3:210-4.
16. Kostoff RN, Patel U. Literature-related discovery and innovation: Chronic kidney disease. Technol Forecast Soc. 2015;91:341-51.
17. Clinical Practice Guidelines and Protocols in British Columbia. Chronic Kidney Disease - Identification, Evaluation and Management of Adult Patients. British Columbia: Ministry of Health; 2014.
18. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975-82.
19. White SL, Hirth R, Mahillo B, Dominguez-Gil B, Delmonico FL, Noel L, et al. The global diffusion of organ transplantation: trends, drivers and policy implications. B World Health Organ. 2014;92(11):826-35. doi: 10.2471/blt.14.137653.
20. Huang JF, Millis JM, Mao YL, Millis MA, Sang XT, Zhong SX. Voluntary organ donation system adapted to Chinese cultural values and social reality. Liver Transplant. 2015;21(4):419-22. doi: 10.1002/lt.24069.
21. Nanjing Finance Bureau: Report on the implementation of the financial budget for 2013 and the budget for the 2014 budget in Nanjing. http://www.njcz.gov.cn/. (2014). Accessed 07 Feb 2014
22. Chan TC, Fan IC, Liu MSY, Su MD, Chiang PH. Addressing health disparities in chronic kidney disease. Inter J Env Res Pub Heal. 2014;11(12):12848-65. doi: 10.3390/ijerph111212848.
23. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80:1258-70.
24. Lin SY. Nephrology in China: a great mission and momentous challenge. Kidney Int. 2003;63:108-10. doi: 10.1046/j.1523-1755.63.s83.22.x.
25. Luyckx VA, Naicker S, McKee M. Equity and economics of kidney disease in sub-Saharan Africa. Lancet. 2013;283:103-4.
26. Dreyer G, Dobbie H, Banks R. Supporting Malawi's dialysis services with the international community. Br J Renal Med. 2012;17:24-6.
27. Vanholder R, Biesen WV, Lameire N. Renal replacement therapy: how can we contain the costs? Lancet. 2014;383:1783-5.
28. Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int. 1996;50:235-42.
29. Garcia GG, Harden P, Chapman J. The global role of kidney transplantation. Saudi J Kidney Dis Transpl. 2012;23:215-22.
30. Dialysis and Transplantation Registration Group, Chinese Society of Nephrology. The report about the registration of dialysis and transplantation in China 1999. Chin J Nephrol. 2001;17(2):77-8.
31. Qaseem A, Hopkins RH, Sweet DE, Starkey M, Shekelle P. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the clinical guidelines committee of the american college of physicians. Ann Intern Med. 2013;159:1-14.